guhjy's statin [114 articles] Export

Recent papers added to guhjy's library classified by the tag statin. You can also see everyone's statin.

	Fluvastatin attenuates IGF-1-induced ERK1/2 activation and cell proliferation by mevalonic acid depletion in human mesangial cells. [My Copy] Life sciences, Vol. 84, No. 21-22. (22 May 2009), pp. 725-731. by Tatsuya Shibata, Masahito Tamura, Narutoshi Kabashima, et al.Ryota Serino, Masaki Tokunaga, Mika Matsumoto, Tetsu Miyamoto, Mieko Miyazaki, Yumi Furuno, Masaaki Takeuchi, Haruhiko Abe, Masahiro Okazaki, Yutaka Otsuji posted to statin mc igf1 erk by guhjy on 2009-12-03 13:23:14 as
	High ambient glucose augments angiotensin II-induced proinflammatory gene mRNA expression in human mesangial cells: effects of valsartan and simvastatin. [My Copy] American journal of nephrology, Vol. 30, No. 2. (2009), pp. 99-111. by Masayo Naito, Ananth Shenoy, Isao Aoyama, et al.Joseph S. Koopmeiners, Radko Komers, H. William Schnaper, Karol Bomsztyk posted to statin mcp1 mc hg cox2 arb aii by guhjy on 2009-12-01 08:38:19 as
	Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR/S6 kinase activity. [My Copy] Cancer research, Vol. 67, No. 20. (15 October 2007), pp. 9878-9886. by Geraldine A. Finlay, Amy J. Malhowski, Yingling Liu, Barry L. Fanburg, David J. Kwiatkowski, Deniz Toksoz posted to tsc statin s6k rho rheb mtor by guhjy on 2009-11-22 12:43:37 as
	Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma. [My Copy] Cancer chemotherapy and pharmacology, Vol. 64, No. 3. (August 2009), pp. 497-507. by Won Kim, Jung-Hwan H. Yoon, Jung-Ryul R. Kim, et al.In-Jin J. Jang, Yung-Jue J. Bang, Yoon-Jun J. Kim, Hyo-Suk S. Lee posted to statin pkc inhibitor hcc by guhjy on 2009-11-21 14:34:13 as
	Synergistic Anti-Fibrotic Efficacy of Statin and Protein Kinase C Inhibitor in Hepatic Fibrosis. [My Copy] American journal of physiology. Gastrointestinal and liver physiology (12 November 2009) by Jong In I. Yang, Jung-Hwan H. Yoon, Yung-Jue J. Bang, et al.Sung-Hee H. Lee, Soo-Mi M. Lee, Hee Jin J. Byun, Sun-Jung J. Myung, Won Kim, Hyo-Suk S. Lee posted to statin pkc lc inhibitor by guhjy on 2009-11-21 14:32:04 as
	First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease. [My Copy] American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 45, No. 3. (March 2005), pp. 473-484. by Colin Baigent, Martin Landray, Craig Leaper, et al.Paul Altmann, Jane Armitage, Alex Baxter, Hugh S. Cairns, Rory Collins, Robert N. Foley, Valeria Frighi, Karen Kourellias, Peter J. Ratcliffe, Mary Rogerson, John E. Scoble, Charles R. Tomson, Graham Warwick, David C. Wheeler posted to statin rct dn aspirin by guhjy on 2009-11-19 06:36:00 as
	Pravastatin and cardiovascular risk in moderate chronic kidney disease☆ [My Copy] Atherosclerosis, Vol. 206, No. 2. (October 2009), pp. 512-517. by Haruo Nakamura, Kyoichi Mizuno, Yasuo Ohashi, Tomowo Yoshida, Koichi Hirao, Yasufumi Uchida posted to statin rct cv ckd by guhjy on 2009-11-19 06:06:41 as
	Should all diabetic patients be treated with a statin? [My Copy] Diabetes care, Vol. 32 Suppl 2 (November 2009) by Yehuda Kamari, Rafael Bitzur, Hofit Cohen, Aviv Shaish, Dror Harats posted to statin dm by guhjy on 2009-11-17 12:09:57 as
	Simvastatin impairs smad-3 phosphorylation and modulates transforming growth factor beta1-mediated activation of intestinal fibroblasts. [My Copy] The British journal of surgery, Vol. 96, No. 5. (May 2009), pp. 541-551. by J. P. Burke, R. W. Watson, M. Murphy, N. G. Docherty, J. C. Coffey, P. R. O'Connell posted to tgfb statin smad fbl by guhjy on 2009-11-17 09:14:22 as
	American Diabetes Association indications for statins in diabetes: is there evidence? [My Copy] Diabetes care, Vol. 32 Suppl 2 (November 2009) by Roy Eldor, Itamar Raz posted to statin gdl dm by guhjy on 2009-11-15 05:00:02 as
	Interpreting clinical trials of diabetic dyslipidaemia: new insights. [My Copy] Diabetes, obesity & metabolism, Vol. 11, No. 3. (March 2009), pp. 261-270. by A. S. Wierzbicki posted to statin rct by guhjy on 2009-11-15 03:02:13 as
	Myopathy with statin-fibrate combination therapy: clinical considerations. [My Copy] Nature reviews. Endocrinology, Vol. 5, No. 9. (September 2009), pp. 507-518. by Terry A. Jacobson posted to statin fibrate by guhjy on 2009-11-15 02:59:36 as
	Combination statin-fibrate therapy: safety aspects. [My Copy] Diabetes, obesity & metabolism, Vol. 11, No. 2. (February 2009), pp. 89-94. by R. Franssen, M. Vergeer, E. S. Stroes, J. J. Kastelein posted to statin fibrate by guhjy on 2009-11-15 02:59:30 as
	Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence. [My Copy] Journal of nephrology, Vol. 22, No. 5. (t 2009), pp. 598-609. by Mehmet Kanbay, Faruk Turgut, Adrian Covic, David Goldsmith posted to statin rt ckd by guhjy on 2009-11-14 07:04:21 as
	Mechanisms Underlying Pleiotropic Effects of Statins. [My Copy] American journal of therapeutics (15 May 2009) by Chandrasekar Palaniswamy, Dhana R. Selvaraj, Thiruvenkadam Selvaraj, Rishi Sukhija posted to statin by guhjy on 2009-11-14 05:22:36 as
	Co-administration of ezetimibe enhances proteinuria-lowering effects of pitavastatin in chronic kidney disease patients partly via a cholesterol-independent manner. [My Copy] Pharmacological research : the official journal of the Italian Pharmacological Society (8 August 2009) by Tsukasa Nakamura, Eiichi Sato, Nobuharu Fujiwara, et al.Yasuhiro Kawagoe, Yoshihiko Ueda, Tsukasa Suzuki, Seiji Ueda, Kei Fukami, Seiya Okuda, Sho-Ichi I. Yamagishi posted to statin proteinuria ckd by guhjy on 2009-11-14 05:16:06 as
	Atorvastatin: its clinical role in cerebrovascular prevention. [My Copy] Drugs, Vol. 67 Suppl 1 (2007), pp. 55-62. by Achille Gaspardone, Marcello Arca posted to statin cv ascot by guhjy on 2009-11-14 04:20:30 as
	Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events. [My Copy] Drugs, Vol. 67 Suppl 1 (2007), pp. 29-42. by Marcello Arca, Achille Gaspardone posted to statin cv ascot by guhjy on 2009-11-14 04:18:38 as
	Statins for the Prevention and Treatment of Infections: A Systematic Review and Meta-analysis [My Copy] Arch Intern Med, Vol. 169, No. 18. (12 October 2009), pp. 1658-1667. by Imad M. Tleyjeh, Tarek Kashour, Fayaz A. Hakim, et al.Valerie A. Zimmerman, Patricia J. Erwin, Alex J. Sutton, Talal Ibrahim posted to statin meta-analysis infection by guhjy on 2009-10-14 08:55:11 as
	Impact of a combined treatment of angiotensin II type 1 receptor blockade and 3-hydroxy-3-methyl-glutaryl-CoA-reductase inhibition on secretory phospholipase A2-type IIA and low density lipoprotein oxidation in patients with coronary artery disease. [My Copy] European heart journal, Vol. 29, No. 16. (August 2008), pp. 1956-1965. by Dimitar Divchev, Christina Grothusen, Maren Luchtefeld, et al.Martin Thoenes, Frederick Onono, Rainer Koch, Helmut Drexler, Bernhard Schieffer posted to statin spla2 pla2 cv arb by guhjy on 2009-09-03 13:42:54 as
	Should statins be prescribed for primary prevention of cardiovascular disease in patients with chronic kidney disease? [My Copy] BMJ (Clinical research ed.), Vol. 339 (2009) by Andrew Connor, Charlie Tomson posted to statin meta-analysis ckd by guhjy on 2009-09-03 06:44:04 as
	Systematic Review: Comparative Effectiveness and Harms of Combinations of Lipid-Modifying Agents and High-Dose Statin Monotherapy. [My Copy] Annals of internal medicine (31 August 2009) by Mukul Sharma, Mohammed T. Ansari, Ahmed M. Abou-Setta, et al.Karla Soares-Weiser, Teik Chye C. Ooi, Margaret Sears, Fatemeh Yazdi, Alexander Tsertsvadze, David Moher posted to statin meta-analysis lipid by guhjy on 2009-09-03 06:41:35 as
	HMG CoA reductase inhibitors (statins) for dialysis patients. [My Copy] Cochrane database of systematic reviews (Online), No. 3. (2009) by Sankar D. Navaneethan, Sagar U. Nigwekar, Vlado Perkovic, David W. Johnson, Jonathan C. Craig, Giovanni F. Strippoli posted to statin meta-analysis esrd by guhjy on 2009-09-03 04:41:58 as
	Additive interaction between the renin-angiotensin system and lipid metabolism for cancer in type 2 diabetes. [My Copy] Diabetes, Vol. 58, No. 7. (July 2009), pp. 1518-1525. by Xilin Yang, Hailu Zhao, Yi Sui, et al.Ronald C. Ma, Wing Yee Y. So, Gary T. Ko, Alice P. Kong, Risa Ozaki, Chun Yip Y. Yeung, Gang Xu, Peter C. Tong, Juliana C. Chan posted to statin lipid dm cancer arb aii acei by guhjy on 2009-09-02 09:43:50 as
	Effect of Atorvastatin and Irbesartan, Alone and in Combination, on Postprandial Endothelial Dysfunction, Oxidative Stress, and Inflammation in Type 2 Diabetic Patients [My Copy] Circulation, Vol. 111, No. 19. (17 May 2005), pp. 2518-2524. by Antonio Ceriello, Roberta Assaloni, Roberto Da Ros, et al.Amabile Maier, Ludovica Piconi, Lisa Quagliaro, Katherine Esposito, Dario Giugliano posted to statin ros inflammation enddysf dm arb by guhjy on 2009-09-02 07:01:17 as
	Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy. [My Copy] Drugs, Vol. 65, No. 1. (2005), pp. 31-74. by Richard J. Woodman, Gerard T. Chew, Gerald F. Watts posted to statin enddysf dm acei by guhjy on 2009-09-02 06:41:05 as
	Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects. [My Copy] Arteriosclerosis, thrombosis, and vascular biology, Vol. 27, No. 3. (March 2007), pp. 556-563. by Eiichiro Yamamoto, Takuro Yamashita, Tomoko Tanaka, et al.Keiichiro Kataoka, Yoshiko Tokutomi, Zhong-Fang F. Lai, Yi-Fei F. Dong, Shinji Matsuba, Hisao Ogawa, Shokei Kim-Mitsuyama posted to statin rat enos dhfr arb akt by guhjy on 2009-08-27 10:00:39 as
	Effect of pitavastatin on type 2 diabetes mellitus nephropathy in KK-Ay/Ta mice [My Copy] Metabolism, Vol. 57, No. 5. (May 2008), pp. 691-697. by M. Matsumoto, M. Tanimoto, T. Gohda, et al.T. Aoki, M. Murakoshi, K. Yamada, T. Yamazaki, S. Kaneko, S. Horikoshi, Y. Tomino posted to gtpch statin no mouse enos dn bh4 by guhjy on 2009-08-27 07:20:25 as
	Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. [My Copy] Atherosclerosis, Vol. 198, No. 1. (May 2008), pp. 65-76. by Philip Wenzel, Andreas Daiber, Matthias Oelze, et al.Moritz Brandt, Ellen Closs, Jian Xu, Thomas Thum, Johann Bauersachs, Georg Ertl, Ming-Hui H. Zou, Ulrich Förstermann, Thomas Münzel posted to uncoupling stz statin no gtpch enos dm dhfr by guhjy on 2009-08-27 05:40:01 as
	Statins potentiate cytostatic/cytotoxic activity of sorafenib but not sunitinib against tumor cell lines in vitro [My Copy] Cancer Letters (25 July 2009) by Jacek Bil, Lukasz Zapala, Dominika Nowis, Marek Jakobisiak, Jakub Golab posted to statin sorafenib cancer by guhjy on 2009-08-17 06:06:01 as
	HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. [My Copy] Cochrane database of systematic reviews (Online), No. 2. (2009) by Sankar D. Navaneethan, Francesca Pansini, Vlado Perkovic, et al.Carlo Manno, Fabio Pellegrini, David W. Johnson, Jonathan C. Craig, Giovanni F. Strippoli posted to statin meta-analysis ckd by guhjy on 2009-08-10 03:44:20 as
	HMG CoA reductase inhibitors (statins) for kidney transplant recipients. [My Copy] Cochrane database of systematic reviews (Online), No. 2. (2009) by Sankar D. Navaneethan, Vlado Perkovic, David W. Johnson, Sagar U. Nigwekar, Jonathan C. Craig, Giovanni F. Strippoli posted to statin rt meta-analysis by guhjy on 2009-08-10 03:44:06 as
	HMG CoA reductase inhibitors (statins) for dialysis patients. [My Copy] Cochrane database of systematic reviews (Online), No. 2. (2009) by Sankar D. Navaneethan, Sagar U. Nigwekar, Vlado Perkovic, David W. Johnson, Jonathan C. Craig, Giovanni Fm F. Strippoli posted to statin meta-analysis esrd by guhjy on 2009-08-10 03:43:46 as
	[Effects of fluvastatin on the expression of Janus kinase 2/signal transducers and activators of transcription (JAK/STAT) in glomerular mesangial cells under high concentration of glucose] [My Copy] Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue, Vol. 20, No. 7. (July 2008), pp. 422-425. by Yong-hong H. Shi, Song Zhao, Yun-zhuo Z. Ren, Qing-juan J. Liu, Hui-jun J. Duan posted to hg mc stat statin by guhjy on 2009-08-08 14:17:06 as
	Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy. [My Copy] Diabetes care, Vol. 28, No. 11. (November 2005), pp. 2728-2732. by Tsukasa Nakamura, Takeshi Sugaya, Yasuhiro Kawagoe, Yoshihiko Ueda, Shiwori Osada, Hikaru Koide posted to dn fabp statin urine by guhjy on 2009-08-08 03:36:12 as
	Connective tissue growth factor expression and induction by transforming growth factor-beta is abrogated by simvastatin via a Rho signaling mechanism. [My Copy] American journal of physiology. Lung cellular and molecular physiology, Vol. 287, No. 6. (December 2004) by Keira L. Watts, Monica A. Spiteri posted to 3 ctgf fbl rho statin tgfb by guhjy on 2009-08-05 09:36:35 as
	Simvastatin inhibits cell cycle progression in glucose-stimulated proliferation of aortic vascular smooth muscle cells by up-regulating cyclin dependent kinase inhibitors and p53. [My Copy] Pharmacological research : the official journal of the Italian Pharmacological Society, Vol. 58, No. 3-4. (t 2008), pp. 247-256. by Kuei-Chuan C. Chan, Chau-Jong J. Wang, Hsieh-Hsun H. Ho, Hsiang-Mei M. Chen, Chien-Ning N. Huang posted to p21 p53 statin vsmc by guhjy on 2009-08-02 00:17:06 as
	Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial. [My Copy] Gastroenterology, Vol. 136, No. 5. (May 2009), pp. 1651-1658. by J. G. Abraldes, A. Albillos, R. Bañares, et al.J. Turnes, R. González, J. C. García-Pagán, J. Bosch posted to lc port-ht rct statin by guhjy on 2009-07-28 10:59:11 as along with 2 people rmclean wagrob
	Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis. [My Copy] Gastroenterology, Vol. 126, No. 3. (March 2004), pp. 749-755. by C. Zafra, J. G. Abraldes, J. Turnes, et al.A. Berzigotti, M. Fernández, J. C. Garca-Pagán, J. Rodés, J. Bosch posted to lc no statin by guhjy on 2009-07-28 10:34:34 as
	Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase. [My Copy] Hepatology (Baltimore, Md.), Vol. 46, No. 1. (July 2007), pp. 242-253. by J. Trebicka, M. Hennenberg, W. Laleman, et al.N. Shelest, E. Biecker, M. Schepke, F. Nevens, T. Sauerbruch, J. Heller posted to lc no port-ht rat rho statin by guhjy on 2009-07-28 10:34:23 as
	Statins and hepatitis C virus: Friend or foe? [My Copy] Hepatology (Baltimore, Md.) (20 May 2009) by Enzo Emanuele posted to hcv statin by guhjy on 2009-07-22 03:21:26 as
	Coomassie stains: are they really mass spectrometry compatible? [My Copy] Rapid communications in mass spectrometry : RCM, Vol. 23, No. 10. (May 2009), pp. 1525-1529. by D. Sumpton, W. Bienvenut posted to 2dge statin by guhjy on 2009-07-14 05:45:49 as along with 1 person robert
	A silver staining procedure for nucleic acids in polyacrylamide gels without fixation and pretreatment. [My Copy] Analytical biochemistry, Vol. 391, No. 1. (1 August 2009), pp. 77-79. by Z. W. An, L. L. Xie, H. Cheng, et al.Y. Zhou, Q. Zhang, X. G. He, H. S. Huang posted to ge statin by guhjy on 2009-07-14 05:34:13 as
	The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation. [My Copy] Diabetologia, Vol. 51, No. 9. (September 2008), pp. 1731-1740. by A. C. Calkin, S. Giunti, K. J. Sheehy, et al.C. Chew, V. Boolell, Y. S. Rajaram, M. E. Cooper, K. A. Jandeleit-Dahm posted to apoe arb cv inflammation mouse rage statin by guhjy on 2009-06-21 02:23:22 as
	Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV coinfected patients. [My Copy] Journal of viral hepatitis, Vol. 16, No. 7. (July 2009), pp. 479-484. by L. Milazzo, L. Meroni, M. Galazzi, et al.M. Cesari, I. Caramma, G. Marchetti, M. Galli, S. Antinori posted to statin hcv by guhjy on 2009-06-18 15:28:18 as
	Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development. [My Copy] Hepatology (Baltimore, Md.), Vol. 50, No. 1. (18 July 2009), pp. 6-16. by L. Delang, J. Paeshuyse, I. Vliegen, et al.P. Leyssen, S. Obeid, D. Durantel, F. Zoulim, A. Op de Beeck, J. Neyts posted to hcv statin by guhjy on 2009-06-18 15:27:58 as
	C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: Inhibitory effects of atorvastatin. [My Copy] International journal of cardiology (5 February 2009) by Nitin Mahajan, Ajay Bahl, Veena Dhawan posted to crp pbmc rage statin by guhjy on 2009-06-18 15:25:04 as
	Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. [My Copy] Lancet, Vol. 373, No. 9670. (4 April 2009), pp. 1175-1182. by P. M. Ridker, E. Danielson, F. A. Fonseca, et al.J. Genest, A. M. Gotto, J. J. Kastelein, W. Koenig, P. Libby, A. J. Lorenzatti, J. G. Macfadyen, B. G. Nordestgaard, J. Shepherd, J. T. Willerson, R. J. Glynn, posted to crp cv rct statin by guhjy on 2009-05-27 05:31:53 as along with 1 person booker
	Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD. [My Copy] American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 53, No. 5. (10 May 2009), pp. 741-750. by Michael J. Koren, Michael H. Davidson, Daniel J. Wilson, et al.Rana S. Fayyad, Andrea Zuckerman, David P. Reed, ALLIANCE Investigators posted to ckd cv rct statin by guhjy on 2009-04-24 03:35:22 as
	The role of statins in chronic kidney disease (CKD): friend or foe? [My Copy] Pharmacology & therapeutics, Vol. 122, No. 3. (4 June 2009), pp. 312-323. by Theodoros I. Kassimatis, Panagiotis A. Konstantinopoulos posted to ckd statin by guhjy on 2009-04-10 03:45:33 as

Note: You may cite this page as: http://www.citeulike.org/user/guhjy/tag/statin

Result page: 1 2 3 Next

ckd	1741
rct	1203
dn	1107
dm	1020
cancer	1013
ma	974
cv	918
hd	859
tgfb	821
snp	765
bp	643
ros	592
meta-analysis	515
uae	500
kidney	492
stats	480
mouse	469
software	463
mirna	448
genetics	447
pt	434
proteomics	411
mortality	408
rat	372
inflammation	367
fbl	366
proteinuria	356
pcr	353
tw	347
acei	332
gdl	331
db	330
test	325
inhibitor	319
mc	315
urine	315
arb	315
method	314
ms	310
irs	309
mtor	309
apoptosis	307
akt	306
age	302
hcv	302
r	294
aging	293
biomarker	287
1	286
ppi	278
bias	277
bayes	275
aii	275
hg	272
aki	269
gwa	268
nutrition	255
emt	255
rnai	248
pi3k	245
ub	240
egfr	239
p53	237
fibrosis	235
obesity	230
cox	228
smad	224
pbmc	223
s6k	223
drug	218
hcc	213
metab	213
gn	210
hypoxia	210
erk	209
herb	203
albumin	189
collagen	187
lc	186
stz	185
nfkb	185
hif	180
longitudinal	179
lmm	178
gfr	174
pubmed	170
ua	170
epigenetics	169
p38	168
japan	165
bioinf	164
cea	163
power	163
gender	162
dna-damage	160
lead	160
rage	160
cadmium	158
ref	154
genomics	150
vitamin-d	148
stata	147
ctgf	147
network	146
pkc	145
liver	144
book	143
company	140
screening	137
diet	136
rt	136
phosphorylation	132
seq	132
mt	130
protein	128
cell-cycle	126
go	126
pathway	126
kinase	124
systems-biology	124
esrd	123
no	122
lipid	118
creatinine	115
statin	114
insulin	112
senescence	109
proliferation	108
mapk	108
podocyte	106
fish	104
regression	103
gfr-formula	102
pd	102
cad	102
case-control	102
imputation	101
multiplicity	100
imaging	99
observational	98
tnf	97
rx	97
cloning	96
plasmid	96
pediatric	96
nox	95
p21	95
methylation	95
recurrent	94
sirt	93
blood	93
betel	93
stat	92
pparg	92
chf	91
nhanes	90
hypertrophy	89
website	89
src	88
anemia	88
phenotype	88
toxicology	88
diagnosis	87
lr	86
immunity	86
uti	85
cytokine	85
epo	84
at1	84
china	83
environment	82
ebm	81
ca	81
p	81
oat	81
nonp	81
hapmap	80
cachexia	80
review	80
ko	79
primer	78
gout	78
qms	77
autophagy	76
signaling	75
promoter	73
cox2	73
missing	73
gene-therapy	73
stone	72
gene-list	72
surrogate	72
lpd	72
eqtl	72
ace	71
p-value	71
mv	71
salt	70
egf	70
eif	69
phd	69
mgo	67
jnk	66
tin	66
uncertainty	66
hts	65
glycemia	65
mirna-target	65
normalization	65
chinese	65
foxo	64
association	64
gpcr	64
enddysf	63
uuo	63
pla2	63
acid-base	63
2dge	63
yeast	63
causation	63
simulation	62
me	62
hsp	62
smoking	62
4ebp	62
shc	61
avf	61
ptm	61
confounding	61
change	60
outcome	60
pe	60
ifn	60
melamine	60
sas	60
infection	60
cost	59
oral	59
oglcnac	59
crp	59
llcpk1	59
mmp	58
nrk49f	58
hk2	58
pai1	58
alcohol	58
achr	57
robust	57
model-selection	57
urate-transporter	57
fluorescence	57
pls	57
aceiarb	56
semantic	56
calibration	56
pdgf	56
ratio	55
rho	55
goldstd	55
competing-risk	55
estrogen	54
bone	54
stem-cell	54
translation	54
ckd-progression	54
iron	54
function	54
workflow	54
std	53
dipstick	53
ace2	53
vegf	53
renoprotection	53
k	53
pld	52
qc	52
histone	52
dimerization	52
fgf	52
ncrna	52
pth	51
atm	51
hdac	51
lod	51
normoalbuminuria	51
cyclin-d1	51
hsc	51
ab	51
epidemiology	51
reasoning	50
mercury	50
risk-ratio	50
graph	50
arsenic	50
tf	50
matlab	50
rapamycin	49
adpkd	49
gene-environment	49
epistasis	49
klotho	49
antibiotics	49
il6	48
core-curriculum	48
ffpe	48
ukm	48
breakpoint	48
nrk52e	48
ngal	48
pooling	47
p27	47
joint-model	47
ecm	47
endothelium	47
spot-urine	47
hgf	46
aldosterone	46
fdr	46
dub	46
cystatin	46
wnt	46
protein-microarray	46
aspirin	46
semip	45
fgf23	45
metal	45
writing	45
mesangial	45
biosensor	45
prevention	45
sumo	44
ras	44
interaction	44
ampk	44
ancova	44
diuretics	44
ccb	44
variability	44
hepatocyte	44
cnv	43
bia	43
irs1	43
klf	43
er-stress	43
enos	43
sle	43
design	43
dbdb	43
na	43
good	42
icu	42
stroke	42
bmi	42
agreement	42
roc	42
tgfbr	41
fuzzy	41
tlr	40
mtorc1	40
hyperfiltration	40
sage	40
wga	40
risk	40
alignment	40
igf	40
qtl	40
gene-targeting	40
ap1	39
dry-bw	39
urinalysis	39
asia	39
rca	39
omics	38
angiogenesis	38
catenin	38
tea	38
igan	38
rvh	38
myc	38
protein-complex	38
antisense	37
hematuria	37
propensity	37
emr	37
animal	37
bh4	37
haplotype	37
adh	37
fabp	37
megalin	36
il1	36
web20	36
inflammasome	36
cardiorenal	36
adenosine	36
gsk	36
s100b	36
cre	35
coffee	35
proteasome	35
threshold	35
calcification	35
exercise	35
reverse-epidemiology	35
chemogenomics	35
adduct	35
subgroup	35
candidate-gene	35
annotation	35
effect-size	34
sp1	34
cross-species	34
attrition	34
sepsis	34
msm	34
pathology	34
snx	34
fibronectin	34
vsmc	34
nephrotoxicity	34
ns	33
zeb	33
bmp	33
sarcopenia	33
integrin	33
cage	33
ecology	33
steroid	32
browser	32
et	32
affy	32
orbitrap	32
ai	32
rsk	32
text-mining	32
zfn	32
addgene	32
end-point	32
fc	32
rtk	32
pdk	31
heritability	31
risk-difference	31
emsa	31
frailty	31
abp	31
macrophage	31
silac	31
hospitalization	31
transactivation	31
set	31
blast	31
gllamm	31
family	31
creb	30
mtorc2	30
knockout	30
carcinogen	30
staging	30
s100	30
mw	30
transporter	30
membrane-protein	30
reporter	30
notch	30
sglt	29
nicotinic	29
extraction	29
geo	29
pka	29
grn	29
ub-ligase	29
perindopril	29
3	29
validation	29
virus	29
nutrient	29
pten	28
gee	28
time-dependent	28
mutagenesis	28
gsk3	28
acetylation	28
race	28
aa	28
scaling	28
thp	27
agt	27
cari	27
ndrd	27
pdz	27
hplc	27
mendelian	27
video	27
renin	27
classification	27
spla2	27
ce	27
thesis	27

guhjy's statin [114 articles] Export

guhjy's tags